iVigee published the Expert Series asking CRO vs. Specialist Pharmacovigilance Provider: Which Should You Actually Choose?

Public source

Publisher name

Public post

Two regulatory updates to watch this week if you file in China or market in the Netherlands. 🇨🇳 China: The Center for Drug Evaluation has opened a public consultation…

Log in to read the full post

Company

iVigee

Industry
Biotechnology Research
Location
Burlington, US
Company size
51–200 employees

About iVigee

iVigee delivers physician-led pharmacovigilance grounded in truth. You receive pharmacovigilance services and consulting across the entire product lifecycle, from clinical development through post-marketing authorization. Our approach is built on transparency, regulatory realism, and straight answers you can trust, so you’re never left guessing. You work with physicians, former regulators, EU QPPVs, and senior safety leaders who understand how pharmacovigilance is evaluated in real inspections. We focus on what regulators actually look for, what they question, and what they expect you to explain, not just what guidance says. We support you as you build, optimize, and transform your pharmacovigilance capabilities, providing clarity at every stage, from early system design through mature, inspection-ready operations. Across everything we do, you always know where you stand, before inspections, before submissions, and before issues become findings. iVigee operates under an ISO 9001: 2015 – certified quality management system, ensuring the way we work is as structured, consistent, and accountable as the systems we help you establish and maintain.

See more

Latest activity

13 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.